Hospitals reduced central line-associated bloodstream infections by 50% between 2008 and 2016, according to a new progress summary by the Centers for Disease Control and Prevention. The report also shows progress by hospitals in reducing other healthcare-associated infections, including catheter-associated urinary tract, surgical site, methicillin-resistant staphylococcus aureus and Clostridium difficile infections. The AHA’s Health Research & Educational Trust affiliate has been working with the CDC to reduce CLABSI, CAUTI, C difficile and MRSA infections in targeted acute care hospitals. HRET also has worked with the Agency for Healthcare Research and Quality’s Comprehensive Unit Based Safety Program to prevent CLABSI and CAUTI infections, and with the Centers for Medicare & Medicaid Services’ Hospital Improvement Innovation Networks to continue to reduce hospital-acquired conditions in the Medicare program.

Headline
The Centers for Disease Control and Prevention July 14 released an advisory on the growing cyclosporiasis cases across the U.S. The advisory said that the…
Headline
The Centers for Disease Control and Prevention has reported 843 cases of cyclosporiasis across 31 states, with 86 people hospitalized. State health departments…
Headline
The Food and Drug Administration has issued an early alert for specific lots of BD ChloraPrep Applicators by Medline because of a potential breach of sterility…
Headline
The Food and Drug Administration has identified a Class I recall of North American Rescue first aid kits containing TRUE METRIX Blood Glucose Monitoring…
Headline
The Food and Drug Administration June 16 announced that a nationwide shortage of stereotactic breast biopsy needles is expected to last through the end of…
Headline
President Trump signed an executive order May 29 that directs the Centers for Disease Control and Prevention and the Advisory Committee on Immunization…